Opaleye Management Inc. Axogen, Inc. Transaction History

Opaleye Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$8.38 - $17.34 $5.87 Million - $12.1 Million	-700,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $2.42 Million - $4.09 Million	-200,000 Reduced 22.22%	700,000 $8.38 Million
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $3.7 Million - $5.09 Million	-200,000 Reduced 18.18%	900,000 $17.8 Million
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $2.92 Million - $4.43 Million	-200,000 Reduced 15.38%	1,100,000 $23.2 Million
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $4.77 Million - $7.83 Million	-140,000 Reduced 9.72%	1,300,000 $47.9 Million
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $9.94 Million - $14.4 Million	-275,000 Reduced 16.03%	1,440,000 $72.4 Million
Q1 2018 May 14, 2018	SELL	$24.4 - $40.25 $6.22 Million - $10.3 Million	-255,000 Reduced 12.94%	1,715,000 $62.6 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $28.9 Million - $38.1 Million	1,970,000	1,970,000 $38.1 Million

181

36.4M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $658M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.